Literature DB >> 9516832

Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.

P S White1, J M Maris, E P Sulman, S J Jensen, S M Kyemba, C P Beltinger, C Allen, D L Kramer, J A Biegel, G M Brodeur.   

Abstract

Cellular, cytogenetic, and molecular evidence indicates that chromosome band 1p36 is often deleted in neuroblastoma cell lines and tumours, suggesting the presence of one or more tumour suppressor genes in this region. We used a multifaceted approach to analyse the commonly deleted region, 28 distal 1p-specific polymorphic loci were used to detect loss of heterozygosity (LOH) in a panel of primary neuroblastoma tumours. Thirty-two of 122 tumours (26%) demonstrated LOH at three or more loci. In addition, a patient with a constitutional deletion of 1p36.2-.3 and two neuroblastoma cell lines with 1p36 abnormalities were characterised by FISH. When combined with the LOH data, a single consensus region of deletion was defined proximally by PLOD and distally by D1S80, a region spanning approximately five megabases. Several proposed candidate tumour suppressor genes, including ID3, CDC2L1, DAN, PAX7, E2F2, TNFR2 and TCEB3, map outside of this region; however, the transcription factor HKR3 cannot be excluded. LOH for 1p is correlated with adverse clinical and biological features and a poor prognosis, but 1p LOH is not an independent predictor of overall survival. To identify additional candidate genes, an integrated physical map of 1p35-36 is being constructed. The current map includes 445 polymerase chain reaction (PCR)-formatted markers and 608 YACs. This map will help identify region-specific transcripts by direct selection and sequencing.

Entities:  

Mesh:

Year:  1997        PMID: 9516832     DOI: 10.1016/s0959-8049(97)00311-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

Review 1.  Monosomy 1p36.

Authors:  A Slavotinek; L G Shaffer; S K Shapira
Journal:  J Med Genet       Date:  1999-09       Impact factor: 6.318

2.  Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis.

Authors:  Valentina Boeva; Stéphanie Jouannet; Romain Daveau; Valérie Combaret; Cécile Pierre-Eugène; Alex Cazes; Caroline Louis-Brennetot; Gudrun Schleiermacher; Sandrine Ferrand; Gaëlle Pierron; Alban Lermine; Thomas Rio Frio; Virginie Raynal; Gilles Vassal; Emmanuel Barillot; Olivier Delattre; Isabelle Janoueix-Lerosey
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

3.  Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivity.

Authors:  Jean Bouquet De Jolinière; Jean Marc Bernard Ayoubi; Luca Gianaroli; Jean Bernard Dubuisson; Jean Gogusev; Anis Feki
Journal:  Front Surg       Date:  2014-05-27

4.  ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator.

Authors:  Arne Jahn; Grishma Rane; Maciej Paszkowski-Rogacz; Sergi Sayols; Alina Bluhm; Chung-Ting Han; Irena Draškovič; José Arturo Londoño-Vallejo; Alan Prem Kumar; Frank Buchholz; Falk Butter; Dennis Kappei
Journal:  EMBO Rep       Date:  2017-05-12       Impact factor: 8.807

5.  Clinicopathological Characteristics of TZAP Expression in Colorectal Cancers.

Authors:  Soo-Jung Jung; Yu-Ri Seo; Won-Jin Park; Yu-Ran Heo; Yun-Han Lee; Shin Kim; Jae-Ho Lee
Journal:  Onco Targets Ther       Date:  2020-12-17       Impact factor: 4.147

6.  CHD5 inhibits metastasis of neuroblastoma.

Authors:  Astrid K Laut; Carmen Dorneburg; Axel Fürstberger; Thomas F E Barth; Hans A Kestler; Klaus-Michael Debatin; Christian Beltinger
Journal:  Oncogene       Date:  2021-11-17       Impact factor: 9.867

7.  A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes.

Authors:  Karl Vandepoele; Vanessa Andries; Nadine Van Roy; Katrien Staes; Jo Vandesompele; Geneviève Laureys; Els De Smet; Geert Berx; Frank Speleman; Frans van Roy
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

8.  CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.

Authors:  Tomoyuki Fujita; Jun Igarashi; Erin R Okawa; Takahiro Gotoh; Jayanthi Manne; Venkatadri Kolla; Jessica Kim; Huaqing Zhao; Bruce R Pawel; Wendy B London; John M Maris; Peter S White; Garrett M Brodeur
Journal:  J Natl Cancer Inst       Date:  2008-06-24       Impact factor: 13.506

9.  TZAP Mutation Leads to Poor Prognosis of Patients with Breast Cancer .

Authors:  Yu-Ran Heo; Moo-Hyun Lee; Sun-Young Kwon; Jihyoung Cho; Jae-Ho Lee
Journal:  Medicina (Kaunas)       Date:  2019-11-18       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.